Wednesday, July 8, 2026

pharma · COVID-19 · Poliomyelitis

Sinovac Research and

Sinovac Research and clinical programs — 115 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Dhaka, CN HQ
2022 Founded
9 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Dhaka, CN
Founded
2022
Employees
9
Programs
115
Drugs
54
Patents
0
Intelligence · Clinical Programs

Sinovac Research and projects

115 ClinicalTrials.gov programs sponsored by Sinovac Research and.

Sinovac Research and has 115 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

Page 3 of 3
  1. PRO-INF4-MA4002-JStz

    Sinovac Research and Development Co.,

    Influenza and Pneumonia

    approved mab completed

    1 trial
  2. PRO-PanFlu-4001

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial
  3. PRO-PanFlu-4001-1

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial
  4. PRO-QINF-4001

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    1 trial
  5. PRO-QINF-4003

    Sinovac Research and Development Co.,

    Seasonal Influenza

    approved mab completed

    1 trial
  6. PRO-nCOV-4010

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    1 trial
  7. Pandemic influenza A/H1N1 vaccine

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial
  8. SARS-CoV-2 Inactivated Vaccine

    Sinovac Research and Development Co.,

    COVID-19

    approved mab active

    2 trials
  9. The live attenuated varicella vaccine and the inactivated hepatitis A vaccine

    Sinovac Research and Development Co.,

    Varicella

    approved mab completed

    1 trial
  10. Two doses of quadrivalent influenza vaccine

    Sinovac Research and Development Co.,

    Seasonal Influenza

    approved mab completed

    1 trial
  11. Vaicella Vaccine+DTaP on Day 0, MMR on Day 30

    Sinovac Research and Development Co.,

    Varicella (chickenpox)

    approved mab active

    1 trial
  12. Varicella vaccine

    Sinovac Research and Development Co.,

    VZV

    approved mab completed

    1 trial
  13. Varicella vaccine+TIV

    Sinovac Research and Development Co.,

    Varicella

    approved mab completed

    1 trial
  14. sIPV

    Sinovac Research and Development Co.,

    Poliomyelitis

    approved mab active

    3 trials
  15. sIPV vaccine /DTaP vaccine

    Sinovac Research and Development Co.,

    Poliomyelitis

    approved mab completed

    1 trial
  16. seasonal split influenza vaccine

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial
  17. trivalent seasonal influenza vaccine

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial
  18. PRO-sIPV-1001-1

    Sinovac Research and Development Co.,

    Poliomyelitis

    mab completed

    1 trial
  19. SA58 Nasal Spray

    Sinovac Research and Development Co.,

    COVID-19

    small molecule active

    2 trials

Frequently asked questions

How many clinical projects does Sinovac Research and have?

115 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.